Live Breaking News & Updates on John Heymach|Page 7

Stay updated with breaking news from John heymach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AACR: Lung cancer outcomes significantly impr

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023. ....

United States , John Heymach , Bristol Myers Squibb , Spectrum Pharmaceuticals , Janssen Pharmaceuticals , Boehringer Ingelheim , Jazz Pharmaceuticals , Eli Lilly Co , University Of Texas Md Anderson Cancer Center , American Association For Cancer Research , Cancer Center , American Association , Cancer Research , Annual Meeting , Neck Medical Oncology , Mirati Therapeutics , Eli Lilly , Curio Science , Blueprint Medicines ,